Condition: Acute Ischemic Stroke · Sponsor: Shanghai QuietD Biotechnology Co., Ltd.
This is a randomized, double-blinded, placebo-controlled study investigating the safety and efficacy of QD202 injection in patients with acute ischemic stroke undergoing thrombolysis excluding endovascular thrombectomy. Up to 120 male and female patients with acute ischemic stroke undergoing thrombolysis excluding endovascular thrombectomy will be dosed with QD202 injection or placebo as a 60 minute intravenous infusion after completion of the thrombolysis procedure on Day 1-5 of the study period. Subjects will undergo interim procedures at Day 7 or the day of discharge, Day 30, and end-of-study procedures on Day 90.
This description comes directly from the study's public registry record.
Yichuan Cai · 86-13524815449 · caiyc@quietdbio.com
Always discuss trial participation with your own doctor first.
| Meizhou People's Hospital | Meizhou, Guangdong, China | Recruiting |
| Luoyang Central Hospital | Luoyang, Henan, China | Recruiting |
| Nanshi Hospital of Nanyang | Nanyang, Henan, China | Recruiting |
| Jilin Province People's Hospital | Changchun, Jilin, China | Recruiting |
| Meihe Hospital the First Hospital of Jilin University | Meihekou, Jilin, China | Recruiting |
| Benxi Central Hospital | Benxi, Liaoning, China | Recruiting |
| General Hospital of Fuxin Mining Industry Group of Liaoning Health Industry Group | Fuxin, Liaoning, China | Recruiting |
| Central Hospital Affiliated to Shenyang Medical College | Shengyang, Liaoning, China | Recruiting |
| General Hospital of Northern Theater Command | Shenyang, Liaoning, China | Recruiting |
| Linyi People's Hospital | Linyi, Shandong, China | Recruiting |
| Weifang People's Hospital | Weifang, Shandong, China | Recruiting |
| Huashan Hospital Fudan University | Shanghai, Shanghai Municipality, China | Recruiting |
+ 2 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07581210